respiratory
Medicines

Cardiac risks of macrolides ‘not negligible’


Researchers are warning against overuse of macrolides after their analysis found clarithromycin was associated with an increased risk of myocardial infarction, arrhythmia, and cardiac mortality. The analysis of cardiac events in almost 110,000 patients taking clarithromycin found it was associated with 1.9 extra myocardial infarctions 0.95 extra cardiac deaths and 0.2 extra arrhythmias for every ...

Already a member?

Enter your email to keep reading.


OR